Charles River Laboratories International, Inc. (CRL) Q2 2011 Earnings Results

Charles River Laboratories Beats on EPS, Stock Down 2.44%

Charles River Laboratories reported an earnings per share of $0.70, exceeding expectations by over 16%. Despite this positive surprise, the stock fell by 2.44% in reaction, indicating that investors may have had concerns beyond the earnings figure, such as broader market conditions or future outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.70	N/A	+16.28%

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Charles River Laboratories Beats on EPS, Stock Down 2.44%

Key numbers

Management commentary

Charles River Laboratories International, Inc.

More earnings this week

Charles River Laboratories Beats on EPS, Stock Down 2.44%

Key numbers

Management commentary